Related Experiment Video
Updated: May 20, 2026

Electrophysiological Assessment of Murine Atria with High-Resolution Optical Mapping
Published on: February 22, 2018
Relevance of calmodulin/CaMKII activation for arrhythmogenesis in the AV block dog
Vincent J A Bourgonje1, Marieke Schoenmakers, Jet D M Beekman
1Department of Medical Physiology, Division Heart & Lungs, University Medical Center Utrecht, Utrecht, The Netherlands. v.j.a.bourgonje@umcutrecht.nl
Background:
The calcium-dependent signaling molecules calcineurin and calcium/calmodulin-dependent protein kinase II (CaMKII) both have been linked to decompensated hypertrophy and arrhythmias. CaMKII is also believed to be involved in acute modulation of ion channels.
Objective:
The purpose of this study was to determine the role of calcineurin and CaMKII in a dog model of compensated hypertrophy and a long QT phenotype.
Methods:
AV block was created in dogs to induce ventricular remodeling, including enhanced susceptibility to dofetilide-induced torsades de pointes arrhythmias. Dogs were treated with cyclosporin A for 3 weeks, which reduced calcineurin activity, as determined by mRNA expression levels of regulator of calcineurin 1 exon 4, but which was unable to prevent structural, contractile, or electrical remodeling and arrhythmias. Biopsies were taken before and at 2 or 9 weeks after AV block. Western blots were performed against phosphorylated and total CaMKII, phospholamban, Akt, and histone deacetylase 4 (HDAC4).
Results:
Chronic AV block showed an increase in Akt, CaMKII and phospholamban phosphorylation levels, but HDAC4 phosphorylation remained unaltered. Dofetilide induced torsades de pointes in vivo and early afterdepolarizations in cardiomyocytes, and increased [Ca(2+)](i) and CaMKII autophosphorylation. Both W-7 and KN-93 treatment counteracted this.
Conclusion:
The calcineurin pathway seems not to be involved in long-term cardiac remodeling of the chronic AV block dog. Although CaMKII is chronically activated, this does not translate to HDAC4 phosphorylation. However, acute CaMKII overactivation is able to initiate arrhythmias based on triggered activity.
Insights
Calcineurin is not involved in long-term cardiac remodeling in dogs. While CaMKII is chronically activated, acute overactivation initiates arrhythmias, highlighting its role in triggered activity.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Calcineurin and CaMKII are calcium-dependent signaling molecules implicated in cardiac hypertrophy and arrhythmias.
- CaMKII is also involved in the acute regulation of ion channels.
Purpose of the Study:
- To investigate the roles of calcineurin and CaMKII in a canine model of compensated cardiac hypertrophy and a long QT syndrome phenotype.
Main Methods:
- Atrioventricular (AV) block was induced in dogs to promote ventricular remodeling and susceptibility to dofetilide-induced torsades de pointes.
- Cyclosporin A treatment reduced calcineurin activity but did not prevent remodeling or arrhythmias.
- Western blotting assessed levels of phosphorylated CaMKII, phospholamban, Akt, and HDAC4.
Main Results:
- Chronic AV block increased phosphorylation of Akt, CaMKII, and phospholamban, but not HDAC4.
- Dofetilide induced torsades de pointes and early afterdepolarizations, with increased intracellular calcium and CaMKII autophosphorylation.
- Pharmacological inhibition of CaMKII (W-7 and KN-93) counteracted these effects.
Conclusions:
- The calcineurin pathway does not appear to contribute to long-term cardiac remodeling in this chronic AV block model.
- Chronic CaMKII activation does not lead to HDAC4 phosphorylation, but acute CaMKII overactivation triggers arrhythmias via triggered activity.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

